Cullinan Therapeutics (CGEM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist

15.780
+0.230+1.48%

Close Nov 1 16:00 ET

15.780
0.0000.00%

Post 16:20 ET

914.87MMarket Cap-5156P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

UBS Launches SMID Cap Biotechs With Cancer, Autoimmunity in Focus
Seeking AlphaOct 24 15:32 ET
Cullinan Oncology Initiated at Buy by UBS
Dow JonesOct 24 07:39 ET · Ratings
UBS Initiates Cullinan Therapeutics(CGEM.US) With Buy Rating, Announces Target Price $30
Moomoo NewsOct 24 06:31 ET · Ratings
Express News | Cullinan Therapeutics Shares Are Trading Higher After the FDA Cleared the Company's IND Application for CLN-978
BenzingaOct 16 09:29 ET
Cullinan Therapeutics Gets FDA Approval for Lupus Treatment Study
WSJOct 16 07:31 ET
Express News | Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for Cln-978 Administered Subcutaneously in Patients With Moderate to Severe Systemic Lupus Erythematosus
ReutersOct 16 07:00 ET

Comments

Jaguar8

Oct 16 06:38

NEWS

$Cullinan Therapeutics (CGEM.US)$
Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus
Cullinan Therapeutics (Nasdaq: CGEM) announced FDA clearance of its Investigational New Drug (IND) Application for CLN-978, allowing its global Phase 1 clinical trial to proceed in the U.S. for patients with moderate to severe systemic lupus erythematosus (SLE). CLN-9...

Jaguar8

Apr 24 09:10

$Cullinan Therapeutics (CGEM.US)$
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

Moomoo Breakfast US

May 12, 2022 07:18

Columns Today's pre-market stock movers: BYND, DIS, F, GM and more

Gainers:
• $Cullinan Therapeutics (CGEM.US)$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors (RIDE.US)$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin (APP.US)$ +15.5%(In reaction to earnings)
• $SmartRent (SMRT.US)$ +15.4%(In reaction to earnings)
• $Coupang (CPNG.US)$ +14.3%(In reaction to earn...